Journal of Clinical Immunology

, Volume 10, Issue 1, pp 52–60

Normal mitogen-induced suppression of the interleukin-6 (IL-6) response and its deficiency in systemic lupus erythematosus

Authors

  • Richard J. Warrington
    • Department of Medicine and ImmunologyUniversity of Manitoba
  • W. John Rutherford
    • Department of Medicine and ImmunologyUniversity of Manitoba
Original Articles

DOI: 10.1007/BF00917498

Cite this article as:
Warrington, R.J. & Rutherford, W.J. J Clin Immunol (1990) 10: 52. doi:10.1007/BF00917498

Abstract

A low-frequency suppressor-cell population in normal peripheral blood inhibits the B-cell CESS response to IL-6, following pokeweed mitogen stimulation. The suppression of IL-6 responsiveness is (i) radiation sensitive, (ii) directed against CESS targets and not mediated by inhibition of IL-6 production, and (iii) associated with nonspecific cytotoxic activity against CESS targets. The generation of these cytolytic cells is also radiation sensitive. A correlation was found between PWM-induced cytotoxicity against CESS and the suppression of IL-6-dependent IgG production. But cytotoxicity toward CESS targets is not responsible for this suppression because (i) IL-2 induces equivalent or greater nonspecific cytotoxicity against CESS in the total absence of suppression of CESS-derived IgG production and (ii) suppression is also induced by mitogen-activated PBL separated from CESS targets by a cell-impermeable membrane. This suppression was not mediated by TNFα/β or IFN-γ. In systemic lupus erythematosus, suppression of IL-6-dependent IgG production is impaired in patients with active disease (29.2±13.7%) compared to patients with inactive disease (70±19.5%) or normal controls (82.8±9.2%). There is also a defect in mitogen-induced nonspecific cytotoxicity in active SLE (specific lysis 15.1±3.5%, compared to 34±4% in normals). Pokeweed mitogen-activated PBL can therefore normally induce suppression of B-cell IL-6 responses and this response is deficient in lupus.

Key words

Systemic lupus erythematosus (SLE)interleukin-6 (IL-6)suppression

Copyright information

© Plenum Publishing Corporation 1990